Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free free
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Iron overload cardiomyopathy: better understanding of an increasing disorder Gujja P; Rosing DR; Tripodi DJ; Shizukuda YJ Am Coll Cardiol 2010[Sep]; 56 (13): 1001-12The prevalence of iron overload cardiomyopathy (IOC) is increasing. The spectrum of symptoms of IOC is varied. Early in the disease process, patients may be asymptomatic, whereas severely overloaded patients can have terminal heart failure complaints that are refractory to treatment. It has been shown that early recognition and intervention may alter outcomes. Biochemical markers and tissue biopsy, which have traditionally been used to diagnose and guide therapy, are not sensitive enough to detect early cardiac iron deposition. Newer diagnostic modalities such as magnetic resonance imaging are noninvasive and can assess quantitative cardiac iron load. Phlebotomy and chelating drugs are suboptimal means of treating IOC; hence, the roles of gene therapy, hepcidin, and calcium channel blockers are being actively investigated. There is a need for the development of clinical guidelines in order to improve the management of this emerging complex disease.|Biomarkers/blood[MESH]|Biopsy[MESH]|Cardiomyopathies/blood/*diagnosis/etiology/*therapy[MESH]|Critical Pathways[MESH]|Echocardiography[MESH]|Humans[MESH]|Iron Overload/blood/complications/*diagnosis/*therapy[MESH]|Iron/physiology[MESH]|Magnetic Resonance Imaging[MESH]|Myocardium/pathology[MESH]|Tomography, X-Ray Computed[MESH] |